#USA #New York #Assisted Reproductive Technology #Legacy Fertility #Sperm Study

Advancing Male Fertility: The Sperm Study by Legacy

Legacy, the premier male fertility clinic and at-home sperm testing platform, has launched an ambitious project titled the Sperm Study. Backed by a significant $1 million investment in research and development, this clinical initiative aims to optimize the use of at-home semen collection for assisted reproductive technologies (ART), including in vitro fertilization (IVF) and intrauterine insemination (IUI). With the enrollment of up to 250 participants across two phases, this study stands as one of the most thorough investigations into the impact of specimen handling on sperm quality and performance. Conducted in collaboration with IVF Academy USA, the Sperm Study seeks to set a new standard in at-home fertility testing.

Why This Study Matters

Currently, the existing validation efforts surrounding at-home semen collection are considerably limited. Prior research predominantly involved only men with normal sperm parameters, relied heavily on courier services for specimen transport, and emphasized short-term sperm motility over a more comprehensive analysis. Significant questions remain about how different sperm qualities perform when shipped under genuine conditions and how these variations influence clinical procedures like IVF and IUI. The Sperm Study aims to fill these critical gaps in knowledge.

What to Expect from the Study

The Sperm Study will look at essential sperm quality metrics, including motility, DNA fragmentation, and the viability of sperm post-thawing, while also assessing the effectiveness of computer-aided sperm analysis (CASA) compared to traditional manual methods for semen evaluation in mail-in testing scenarios.

Dr. Scott Lundy, Legacy's Chief Medical Officer, highlighted the increasing demand for at-home sperm testing and the resultant necessity to verify that these samples can perform effectively in reproductive technology contexts. He stated, “With the increased utilization of at-home semen testing and cryopreservation, there is a critical need to ensure these specimens will perform adequately when used for assisted reproduction.”

A Detailed Analysis

The study's design involves an extensive, cross-sectional analysis of semen samples taken at various stages, including the shipment phase. Importantly, the study will incorporate a diverse population, examining men beyond just those with normative sperm. Key aspects include:

• - Direct comparisons between CASA and manual semen analysis at the baseline.
• - Investigating the decline in sperm motility over time and relative to shipping conditions.
• - Assessing DNA fragmentation before and after shipment and cryopreservation.
• - Evaluating post-thaw sperm viability and yield.
• - Developing predictive models for the adequacy of samples for IVF and IUI.

The study will also assess how transit time, sperm concentration, and storage conditions impact final outcomes, thus generating insights that hold potential for wider clinical applications.

The Phased Approach

The Sperm Study will unfold in phases, starting with Phase 1, which will involve 100 participants and roughly 1,500 assays, anticipated to wrap up by the end of 2026. Following this, Phase 2 will expand participant enrollment to 250, aimed at further broad validation among a more extensive patient base.

Implications for Clinical Practice

The findings from the Sperm Study are expected to provide critical guidance for the standardization of specimen collection protocols in at-home settings, as well as shipping and handling practices for semen samples. This research strives to enhance protocols for cryopreservation and inform decisions in IVF and IUI readiness, boosting confidence for fertility clinics, researchers, and patients alike in the use of mail-in semen tests as a vital part of reproductive care.

About Legacy

Legacy has established itself as the foremost male fertility clinic in the U.S., offering a range of services, including at-home semen analysis and sperm cryopreservation. With a CLIA-certified andrology laboratory and one of the most extensive data sets in male reproductive health, Legacy is on a mission to enhance access and innovate within the fertility care sector.